REQUEST A DEMO
Total
USD $0.00
Search more companies

Hanga-Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Hanga-Pharma Gyogyszerkereskedelmi es Szolgaltato Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Hanga-Pharma Bt. is an enterprise located in Hungary, with the main office in Vecses. The company operates in the Pharmacies and Drug Stores sector. It was established on April 27, 1998. There are currently 7 (2024) people employed by Hanga-Pharma Bt.. In 2023, the company reported a net sales revenue increase of 19.16%. Its’ total assets recorded a growth of 10.44%. Hanga-Pharma Bt.’s net profit margin increased by 0.64% in 2023.

Headquarters
Karoly utca 20. A. ep.
Vecses; Pest; Postal Code: 2220

Contact Details: Purchase the Hanga-Pharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Hanga-Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Hanga-Pharma Bt. report to view the information.
Registered Capital:
Purchase the Hanga-Pharma Bt. report to view the information.
Financial Auditors:
Purchase the Hanga-Pharma Bt. report to view the information.
Incorporation Date:
April 27, 1998
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Hanga-Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
19.16%
Total operating revenue
20.05%
Operating profit (EBIT)
29.85%
EBITDA
28.85%
Net Profit (Loss) for the Period
30.23%
Total assets
10.44%
Total equity
24.46%
Operating Profit Margin (ROS)
0.67%
Net Profit Margin
0.64%
Return on Equity (ROE)
0.87%
Quick Ratio
4.88%
Cash Ratio
3.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?